Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−17.30 MXN
−186.20 M MXN
0.00 MXN
About Bionomics Limited - American Depository Shares
Sector
CEO
Spyridon Papapetropoulos
Headquarters
Eastwood
Website
Founded
1996
FIGI
BBG01633F2W9
Bionomics Ltd. is a clinical stage biopharmaceutical company, which develops novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need. Its lead product candidate is BNC210. The company was founded in 1996 and is headquartered in Eastwood, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.